| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.32 | 0.06 |